Annual EBIT:
$575.23M+$208.14M(+56.70%)Summary
- As of today, HALO annual earnings before interest & taxes is $575.23 million, with the most recent change of +$208.14 million (+56.70%) on December 31, 2024.
- During the last 3 years, HALO annual EBIT has risen by +$319.18 million (+124.66%).
- HALO annual EBIT is now at all-time high.
Performance
HALO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$217.92M+$15.48M(+7.65%)Summary
- As of today, HALO quarterly earnings before interest & taxes is $217.92 million, with the most recent change of +$15.48 million (+7.65%) on September 30, 2025.
- Over the past year, HALO quarterly EBIT has increased by +$54.72 million (+33.53%).
- HALO quarterly EBIT is now at all-time high.
Performance
HALO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$737.40M+$54.72M(+8.02%)Summary
- As of today, HALO TTM earnings before interest & taxes is $737.40 million, with the most recent change of +$54.72 million (+8.02%) on September 30, 2025.
- Over the past year, HALO TTM EBIT has increased by +$260.39 million (+54.59%).
- HALO TTM EBIT is now at all-time high.
Performance
HALO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
HALO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +56.7% | +33.5% | +54.6% |
| 3Y3 Years | +124.7% | +160.4% | +174.6% |
| 5Y5 Years | +1048.8% | +440.8% | +1025.3% |
HALO EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +124.7% | at high | +305.0% | at high | +177.2% |
| 5Y | 5-Year | at high | +1048.8% | at high | +440.8% | at high | +1025.3% |
| All-Time | All-Time | at high | +802.5% | at high | +891.7% | at high | +850.0% |
HALO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $217.92M(+7.6%) | $737.40M(+8.0%) |
| Jun 2025 | - | $202.44M(+43.0%) | $682.67M(+14.3%) |
| Mar 2025 | - | $141.53M(-19.4%) | $597.47M(+8.3%) |
| Dec 2024 | $575.23M(+56.7%) | $175.50M(+7.5%) | $551.48M(+15.6%) |
| Sep 2024 | - | $163.20M(+39.2%) | $477.01M(+18.6%) |
| Jun 2024 | - | $117.23M(+22.7%) | $402.09M(+6.0%) |
| Mar 2024 | - | $95.54M(-5.4%) | $379.31M(+12.4%) |
| Dec 2023 | $367.09M(+38.1%) | $101.03M(+14.4%) | $337.57M(+8.0%) |
| Sep 2023 | - | $88.28M(-6.5%) | $312.45M(+1.5%) |
| Jun 2023 | - | $94.46M(+75.6%) | $307.86M(+15.7%) |
| Mar 2023 | - | $53.80M(-29.1%) | $266.06M(-7.6%) |
| Dec 2022 | $265.87M(+3.8%) | $75.91M(-9.3%) | $287.93M(+7.2%) |
| Sep 2022 | - | $83.69M(+58.9%) | $268.56M(+3.1%) |
| Jun 2022 | - | $52.66M(-30.4%) | $260.45M(-13.4%) |
| Mar 2022 | - | $75.67M(+33.8%) | $300.84M(+9.0%) |
| Dec 2021 | $256.04M(+71.1%) | $56.53M(-25.2%) | $275.90M(-7.1%) |
| Sep 2021 | - | $75.59M(-18.8%) | $296.99M(+13.5%) |
| Jun 2021 | - | $93.05M(+83.4%) | $261.70M(+32.0%) |
| Mar 2021 | - | $50.73M(-34.6%) | $198.21M(+37.4%) |
| Dec 2020 | $149.68M(+346.9%) | $77.62M(+92.6%) | $144.25M(+120.1%) |
| Sep 2020 | - | $40.30M(+36.4%) | $65.53M(+9369.4%) |
| Jun 2020 | - | $29.55M(+1017.0%) | $692.00K(+101.6%) |
| Mar 2020 | - | -$3.22M(-192.2%) | -$42.84M(-16.9%) |
| Dec 2019 | -$60.62M(+1.8%) | -$1.10M(+95.5%) | -$36.65M(-2.9%) |
| Sep 2019 | - | -$24.54M(-75.6%) | -$35.62M(+2.6%) |
| Jun 2019 | - | -$13.98M(-571.2%) | -$36.56M(+14.3%) |
| Mar 2019 | - | $2.97M(+4277.5%) | -$42.65M(+38.5%) |
| Dec 2018 | -$61.75M(-173.9%) | -$71.00K(+99.7%) | -$69.33M(-222.3%) |
| Sep 2018 | - | -$25.47M(-26.9%) | $56.67M(-37.2%) |
| Jun 2018 | - | -$20.07M(+15.3%) | $90.22M(+6.4%) |
| Mar 2018 | - | -$23.71M(-118.8%) | $84.82M(+4.7%) |
| Dec 2017 | $83.59M(+202.1%) | $125.93M(+1459.1%) | $81.00M(+220.0%) |
| Sep 2017 | - | $8.08M(+131.7%) | -$67.50M(+31.3%) |
| Jun 2017 | - | -$25.48M(+7.4%) | -$98.32M(-4.0%) |
| Mar 2017 | - | -$27.53M(-21.9%) | -$94.57M(-13.6%) |
| Dec 2016 | -$81.88M(-202.9%) | -$22.57M(+0.7%) | -$83.21M(-50.8%) |
| Sep 2016 | - | -$22.74M(-4.7%) | -$55.17M(+0.9%) |
| Jun 2016 | - | -$21.72M(-34.3%) | -$55.66M(-87.4%) |
| Mar 2016 | - | -$16.17M(-395.9%) | -$29.71M(-8.2%) |
| Dec 2015 | -$27.03M(+57.0%) | $5.46M(+123.5%) | -$27.45M(+25.3%) |
| Sep 2015 | - | -$23.24M(-649.2%) | -$36.77M(-12.9%) |
| Jun 2015 | - | $4.23M(+130.4%) | -$32.56M(+37.1%) |
| Mar 2015 | - | -$13.91M(-261.2%) | -$51.73M(+17.9%) |
| Dec 2014 | -$62.79M(+21.7%) | -$3.85M(+79.8%) | -$63.04M(+21.7%) |
| Sep 2014 | - | -$19.03M(-27.3%) | -$80.51M(-0.7%) |
| Jun 2014 | - | -$14.94M(+40.8%) | -$79.98M(+8.2%) |
| Mar 2014 | - | -$25.22M(-18.3%) | -$87.16M(-8.4%) |
| Dec 2013 | -$80.20M | -$21.32M(-15.3%) | -$80.43M(-26.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$18.49M(+16.4%) | -$63.52M(+2.4%) |
| Jun 2013 | - | -$22.12M(-19.6%) | -$65.05M(-14.2%) |
| Mar 2013 | - | -$18.50M(-319.7%) | -$56.98M(-6.3%) |
| Dec 2012 | -$53.55M(-170.9%) | -$4.41M(+78.0%) | -$53.63M(+20.7%) |
| Sep 2012 | - | -$20.03M(-42.6%) | -$67.65M(-59.3%) |
| Jun 2012 | - | -$14.05M(+7.2%) | -$42.46M(-67.7%) |
| Mar 2012 | - | -$15.14M(+17.8%) | -$25.32M(-27.6%) |
| Dec 2011 | -$19.77M(+63.6%) | -$18.43M(-457.6%) | -$19.84M(-15.5%) |
| Sep 2011 | - | $5.15M(+66.4%) | -$17.17M(+50.6%) |
| Jun 2011 | - | $3.10M(+132.0%) | -$34.76M(+30.5%) |
| Mar 2011 | - | -$9.66M(+38.7%) | -$50.01M(+4.1%) |
| Dec 2010 | -$54.26M(+7.2%) | -$15.76M(-26.8%) | -$52.14M(-6.3%) |
| Sep 2010 | - | -$12.43M(-2.3%) | -$49.05M(+3.0%) |
| Jun 2010 | - | -$12.15M(-3.1%) | -$50.56M(+8.9%) |
| Mar 2010 | - | -$11.79M(+7.0%) | -$55.49M(+5.1%) |
| Dec 2009 | -$58.46M(-15.9%) | -$12.68M(+9.1%) | -$58.46M(+6.9%) |
| Sep 2009 | - | -$13.94M(+18.4%) | -$62.81M(-4.6%) |
| Jun 2009 | - | -$17.08M(-15.8%) | -$60.07M(-10.5%) |
| Mar 2009 | - | -$14.76M(+13.3%) | -$54.36M(-7.8%) |
| Dec 2008 | -$50.43M(-79.2%) | -$17.03M(-52.0%) | -$50.43M(-16.4%) |
| Sep 2008 | - | -$11.20M(+1.5%) | -$43.34M(-7.1%) |
| Jun 2008 | - | -$11.37M(-5.0%) | -$40.45M(-15.9%) |
| Mar 2008 | - | -$10.83M(-9.1%) | -$34.90M(-24.0%) |
| Dec 2007 | -$28.15M(-80.6%) | -$9.93M(-19.5%) | -$28.15M(-23.0%) |
| Sep 2007 | - | -$8.31M(-42.5%) | -$22.89M(-24.4%) |
| Jun 2007 | - | -$5.83M(-42.9%) | -$18.41M(-15.1%) |
| Mar 2007 | - | -$4.08M(+12.6%) | -$15.99M(-2.6%) |
| Dec 2006 | -$15.58M(-14.9%) | -$4.67M(-22.0%) | -$15.58M(-7.5%) |
| Sep 2006 | - | -$3.83M(-12.0%) | -$14.49M(-0.4%) |
| Jun 2006 | - | -$3.42M(+7.0%) | -$14.43M(-3.4%) |
| Mar 2006 | - | -$3.67M(-2.6%) | -$13.96M(-3.0%) |
| Dec 2005 | -$13.56M(-49.2%) | -$3.58M(+5.0%) | -$13.56M(-8.4%) |
| Sep 2005 | - | -$3.77M(-27.8%) | -$12.51M(-4.2%) |
| Jun 2005 | - | -$2.95M(+9.9%) | -$12.01M(-7.7%) |
| Mar 2005 | - | -$3.27M(-29.4%) | -$11.15M(-22.7%) |
| Dec 2004 | -$9.09M(>-9900.0%) | -$2.53M(+22.5%) | -$9.09M(-37.4%) |
| Sep 2004 | - | -$3.26M(-56.2%) | -$6.61M(-96.8%) |
| Jun 2004 | - | -$2.09M(-73.0%) | -$3.36M(-163.3%) |
| Mar 2004 | - | -$1.21M(-2107.5%) | -$1.28M(-1534.4%) |
| Dec 2003 | $0.00(0.0%) | -$54.70K(-475.8%) | -$78.10K(-76.3%) |
| Sep 2003 | - | -$9500.00(-97.9%) | -$44.30K(+6.5%) |
| Jun 2003 | - | -$4800.00(+47.3%) | -$47.40K(+22.2%) |
| Mar 2003 | - | -$9100.00(+56.5%) | -$60.90K(-54.6%) |
| Dec 2002 | $0.00(+100.0%) | -$20.90K(-65.9%) | -$39.40K(-113.0%) |
| Sep 2002 | - | -$12.60K(+31.1%) | -$18.50K(-213.6%) |
| Jun 2002 | - | -$18.30K(-247.6%) | -$5900.00(-147.6%) |
| Mar 2002 | - | $12.40K | $12.40K |
| Dec 2001 | -$39.70K | - | - |
FAQ
- What is Halozyme Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. annual EBIT year-on-year change?
- What is Halozyme Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Halozyme Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. TTM EBIT year-on-year change?
What is Halozyme Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of HALO is $575.23M
What is the all-time high annual EBIT for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high annual earnings before interest & taxes is $575.23M
What is Halozyme Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, HALO annual earnings before interest & taxes has changed by +$208.14M (+56.70%)
What is Halozyme Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of HALO is $217.92M
What is the all-time high quarterly EBIT for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $217.92M
What is Halozyme Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, HALO quarterly earnings before interest & taxes has changed by +$54.72M (+33.53%)
What is Halozyme Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of HALO is $737.40M
What is the all-time high TTM EBIT for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $737.40M
What is Halozyme Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, HALO TTM earnings before interest & taxes has changed by +$260.39M (+54.59%)